Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

Ovarian cancer is one of those. Ovarian cancer starts in the ovaries, which are two small glands located on either side of the uterus that produce eggs and important hormones like estrogen and ...

To optimize treatment outcomes for patients whose late-stage cancer shows resistance to the standard treatment, Sarasota Memorial Research Institute will participate in testing an experimental ...

A potential maintenance therapy for women with advanced ovarian cancer by ArtemiLife received positive results from a Phase 1 clinical trial investigating the product, ArtemiCafe®, a commercially ...

Black and American Indian patients are less likely to have elevated CA-125 levels compared with White patients.

UK biotech Epsilogen has bought US-based TigaTx, pooling their resources to create what it says will be a leader in ...

A new case report was published in Oncoscience's Volume 12 on March 31, 2025, titled "Cystadenofibroma and contralateral collision lesions: A unique ovarian case report." ...

Mar. 13, 2025 — A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States ...

Antibody-drug conjugates and their development remains a central theme in ongoing research within the realm of ovarian cancer ...

Last year, African giant pouched rats like Carolina prevented nearly 400,000 new cases of a deadly disease. It's possible because of their extreme sense of smell. Carolina, an African giant ...

Shares of Johnson & Johnson (NYSE: JNJ) are tumbling on Tuesday. The drop comes as the S&P 500 and Nasdaq Composite were down ...

Johnson & Johnson faces a setback in its talc cases bankruptcy plan but reaffirms confidence in financial guidance. Read more ...